Epidemiology of psoriasis among the elderly population and volume of specialized medical care provided to patients with psoriasis in the Russian Federation in 2010–2019
- Authors: Kubanov A.A.1, Bogdanova E.E.1
-
Affiliations:
- State Scientific Centre of Dermatovenereology and Cosmetology of the Ministry of Health of the Russian Federation
- Issue: Vol 96, No 5 (2020)
- Pages: 7-18
- Section: ORGANIZATION OF HEALTH CARE AND EPIDEMIOLOGY
- URL: https://ogarev-online.ru/0042-4609/article/view/117521
- DOI: https://doi.org/10.25208/vdv1171-2020-96-5-07-18
- ID: 117521
Cite item
Full Text
Abstract
Background. Population ageing is ongoing in the Russian Federation. Demographic changes may influence the age structure and dynamics of epidemiological rates of chronic skin disorders, as well as the need of elderly patients in specialized medical care.
Aims. To study the dynamics of number of cases, incidence and prevalence of psoriasis, and the dynamics of the number of hospital admissions for psoriasis among elderly population (males 60 years and older, females 55 years and older) in 2010–2019 in the Russian Federation.
Materials and methods. Analysis of federal statistic surveillance data, psoriasis prevalence and incidence rates among different age groups of population.
Results. In the Russian Federation there is an increase in absolute number of cases, prevalence and incidence rates of psoriasis among elderly population. There is an increase in the number of hospital admissions due to psoriasis among patients with psoriasis of this age.
Conclusions. An increase of the number and proportion of cases of psoriasis among elderly population is due to both, an increase of prevalence and incidence rates in this age group and population ageing. There is a high need in specialized medical care among elderly population with psoriasis.
Full Text
##article.viewOnOriginalSite##About the authors
A. A. Kubanov
State Scientific Centre of Dermatovenereology and Cosmetology of the Ministry of Health of the Russian Federation
Email: alex@cnikvi.ru
Russian Federation
E. E. Bogdanova
State Scientific Centre of Dermatovenereology and Cosmetology of the Ministry of Health of the Russian Federation
Author for correspondence.
Email: onama@mail.ru
Russian Federation
References
- Бараненкова Т.А. Старение населения и его социально-экономические последствия. Вестник Института экономики Российской академии наук. 2017;2:47–64. [Baranenkova TA. Population ageing and its social and economic impact. Vestnik Instituta economiki Rossiiskoi akademii nauk. 2017;2:47–64 (In Russ.)]
- Кузин С.И. Старение населения: социально-экономический аспект. Вестник университета. 2018;3:137–143. [Kuzin SI. Population ageing: social and economic aspect. Vestnik universiteta. 2018;3:137–143 (In Russ.)]
- Соловьев А.К. Старение населения как угроза бюджетного кризиса: актуальный анализ. ЭКО. 2016;4:141–160. [Soloviev AK. Population ageing as a threat of budjet crisis: relevant analysis. EKO. 2016;4:141–160 (In Russ.)]
- Указ Президента РФ от 6 июня 2019 г. № 254 «О Стратегии развития здравоохранения в Российской Федерации на период до 2025 года». [Russian Federation Presidential Decree of 6 June 2019 “About Public Health Service Development Strategy for the period till 2025”. (In Russ.)]
- Прогноз долгосрочного социально-экономического развития Российской Федерации на период до 2030 года (разработан Минэкономразвития России). Доступен: http://www.consultant.ru/document/cons_doc_LAW_144190/. [Long-term Prognosis of Social-economic Development for the period till 2030 (by Ministry of Economic Development). Available at: http://www.consultant.ru/document/cons_doc_LAW_144190/. (In Russ.)]
- Федеральная служба государственной статистики. Численность населения Российской Федерации по полу и возрасту на 1 января 2019 года (Статистический бюллетень). Москва, 2019 год. Доступно по ссылке: https://rosstat.gov.ru/compendium/document/13284. [Federal State Statistics Service. Russian Federation Population Base by gender and age on 1 January 2019 (Statistical bulletin). Moscow, 2019. Available at: https://rosstat.gov.ru/compendium/document/13284. (In Russ.)]
- Федеральная служба государственной статистики. Численность населения Российской Федерации по полу и возрасту на 1 января 2010 года (Статистический бюллетень). Москва, 2010 год. Доступно по ссылке: https://rosstat.gov.ru/compendium/document/13284. [Federal State Statistics Service. Russian Federation Population Base by gender and age on 1 January 2010 (Statistical bulletin). Moscow, 2010. Available at: https://rosstat.gov.ru/compendium/document/13284. (In Russ.)]
- Springate DA, Parisi R, Kontopantelis E, Reeves D, Griffiths CE, Ashcroft DM. Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study. Br J Dermatol. 2017;176(3):650–658. doi: 10.1111/bjd.15021.
- Eder L, Widdifield J, Rosen CF, Cook R, Lee KA, Alhusayen R, et al. Trends in the Prevalence and Incidence of Psoriasis and Psoriatic Arthritis in Ontario, Canada: A Population-Based Study. Arthritis Care Res (Hoboken). 2019;71(8):1084–1091. doi: 10.1002/acr.23743.
- Wei JC, Shi LH, Huang JY, Wu XF, Wu R, Chiou JY. Epidemiology and Medication Pattern Change of Psoriatic Diseases in Taiwan from 2000 to 2013: A Nationwide, Population-based Cohort Study. J Rheumatol. 2018;45(3):385–392. doi: 10.3899/jrheum.170516.
- Schonmann Y, Ashcroft DM, Iskandar IYK, Parisi R, Sde-Or S, Comaneshter D, et al. Incidence and prevalence of psoriasis in Israel between 2011 and 2017. J Eur Acad Dermatol Venereol. 2019;33(11):2075–2081. doi: 10.1111/jdv.15762. doi: 10.1111/jdv.15762.
- Han JH, Lee JH, Han KD, Seo H-M, Bang CH, Lee JY, et al. Epidemiology and Medication Trends in Patients with Psoriasis: A Nationwide Population-based Cohort Study from Korea. Acta Derm Venereol. 2018;98(4):396–400. doi: 10.2340/00015555-2877.
- Egeberg A, Skov L, Gislason GH, Thyssen JP, Mallbris L. Incidence and Prevalence of Psoriasis in Denmark. Acta Derm Venereol. 2017;97(7):808–812. doi: 10.2340/00015555-2672.
- Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths C, Ashcroft DM. National, regional and worldwide epidemiology of psoriasis: systematic analysis and modeling study. BMJ 2020;369:m1590 doi: 10.1136/bmj.m1590.
- WHO Library Cataloguing-in-Publication Data. World report on ageing and health. © World Health Organization 2015.
- Shalom G, Zisman D, Babaev M, Horev A, Tiosano S, Schonmann Y, et al. Psoriasis in Israel: demographic, epidemiology, and healthcare services utilization. Int J Dermatol. 2018;57(9):1068–1074. doi: 10.1111/ijd.14130.
- Feldman SR, Burudpakdee C, Gala S, Nanavaty M, Mallya UG. The economic burden of psoriasis: a systematic literature review. Expert Rev Pharmacoecon Outcomes Res. 2014;14(5):685–705. doi: 10.1586/14737167.2014.933671.
- Thomsen SF, Skov L, Dodge R, Hedegaard MS, Kjellberg J. Socioeconomic Costs and Health Inequalities from Psoriasis: A Cohort Study. Dermatology. 2019;235(5):372–379. doi: 10.1159/000499924.
- Schonmann Y, Ashcroft DM, Iskandar IYK, Parisi R, Sde-Or S, Comaneshter D, et al. Incidence and prevalence of psoriasis in Israel between 2011 and 2017. J Eur Acad Dermatol Venereol. 2019;33(11):2075–2081. doi: 10.1111/jdv.15762.
- Feldman SR, Zhao Y, Shi L, Tran MH. Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis. J Manag Care Spec Pharm. 2015;21(10):874–888. doi: 10.18553/jmcp.2015.21.10.874.
- Esposti LD, Perrone V, Sangiorgi D, Buda S, Andretta M, Rossini M, et al. Analysis of drug utilization and health care resource consumption in patients with psoriasis and psoriatic arthritis before and after treatment with biological therapies. Biologics. 2018;12:151–158. Published 2018 Nov 12. doi: 10.2147/BTT.S168691.
- Mustonen A, Leino M, Mattila K, Koulu L, Tuominen R. Treatment costs of psoriasis in a tertiary-level clinic. BMC Health Serv Res. 2014;14:344. Published 2014 Aug 15. doi: 10.1186/1472-6963-14-344.
- Polivka L, Oubaya N, Bachelez H, Paul C, Richard MA, Beylot-Barry M, et al. Trends in hospitalization rates for psoriasis flares since the introduction of biologics: a time series in France between 2005 and 2015. J Eur Acad Dermatol Venereol. 2018;32(11):1920–1929. doi: 10.1111/jdv.15044.
- Di Lernia V, Goldust M. An overview of the efficacy and safety of systemic treatments for psoriasis in the elderly. Expert Opin Biol Ther. 2018;18(8):897–903. doi: 10.1080/14712598.2018.1504016.
- Phan C, Sigal ML, Estève E, Reguiai Z, Barthélémy H, Beneton N, et al. Psoriasis in the elderly: epidemiological and clinical aspects, and evaluation of patients with very late onset psoriasis. J Eur Acad Dermatol Venereol. 2016;30(1):78–82. doi: 10.1111/jdv.12850.
- Doshi JA, Takeshita J, Pinto L, Li P, Yu X, Rao P, et al. Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population. J Am Acad Dermatol. 2016;74(6):1057–1065.e4. doi: 10.1016/j.jaad.2016.01.048.
- Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel JP, et al. Lancet 2016 May 21;387(10033):2145–2154.
- Kostović K, Žužul K, Čeović R, Bukvić Mokos Z. Psoriasis in the mature patient: Therapeutic approach in the era of biologics. Clin Dermatol. 2018;36(2):222–230. doi: 10.1016/j.clindermatol.2017.10.013.
- Piaserico S, Conti A, Lo Console F, De Simone C, Prestinari F, Mazzotta A, et al. Efficacy and safety of systemic treatments for psoriasis in elderly patients. Acta Derm Venereol. 2014;94(3):293–297. doi: 10.2340/00015555-1719.
- Sandhu VK, Ighani A, Fleming P, Lynde CW. Biologic Treatment in Elderly Patients with Psoriasis: A Systematic Review. J Cutan Med Surg. 2020;24(2):174–186. doi: 10.1177/1203475419897578.
- Garcia-Doval I, Carretero G, Vanaclocha F, Ferrandiz C, Daudén E, Sánchez-Carazo JL, et al. Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials. Arch Dermatol. 2012 Apr;148(4):463–70. doi: 10.1001/archdermatol.2011.2768.
- Medina C, Carretero G, Ferrandiz C, Dauden E, Vanaclocha F, Gómez-García FJ, et al.; BIOBADADERM Study Group. Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry. J Eur Acad Dermatol Venereol. 2015 May;29(5):858–64. doi: 10.1111/jdv.12688. Epub 2014 Sep 3.
- Maul JT, Navarini AA, Sommer R, Anzengruber F, Sorbe C, Mrowietz U, et al. Gender and age significantly determine patient needs and treatment goals in psoriasis — a lesson for practice. J Eur Acad Dermatol Venereol. 2019 Apr;33(4):700–708. doi: 10.1111/jdv.15324. Epub 2019 Jan 15.
Supplementary files
